Company
Daxor Corporation
Headquarters: New York, NY, United States
CEO: Mr. Michael Richard Feldschuh
Market Cap
$47.2 Million
USD as of Jan. 1, 2024
Daxor Corporation Categories
United States Healthcare Medical Instruments & SuppliesUnited States Healthcare United States Medical Instruments & Supplies
Top Competitors by Market Capitalization
Industry: Medical Instruments & Supplies
| Company | Market Cap (USD) |
|---|---|
| Intuitive Surgical, Inc. | $113.81 B |
| EssilorLuxottica SA | $90.57 B |
| Becton, Dickinson and Company | $70.33 B |
| HOYA Corp | $43.39 B |
| Alcon Inc. | $37.65 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Daxor Corporation has the following listings and related stock indices.
Stock: NYSE: DXR wb_incandescent